Industry Satellite Symposia
Switch To Module
ESMO Congress 2021 - Conference Calendar
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Digital Evaluations
Everything
Everything
Session Title
Session Number
Presentation Title
Presentation Number
Author
Presenter
Chair
Filter By
Day
Select All
Deselect All
Fri, 17.09.2021
12
Sat, 18.09.2021
11
Sun, 19.09.2021
12
Mon, 20.09.2021
11
Tue, 21.09.2021
11
Room
Select All
Deselect All
Channel 3
14
Channel 4
15
Channel 5
13
Channel 6
15
Session Type
Select All
Deselect All
Industry Satellite Symposium
57
Presentation Type
Select All
Deselect All
Invited Speaker
57
Presentation Topic
Select All
Deselect All
General interest
57
Cancel
Clear
Search
Advanced Search
Sign in
Scheduled sessions
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Final Programme PDF
Browsing Over 57 Sessions
Sort By
Upcoming First
Upcoming First
Relevance
Session Number
Session Datetime
Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
(ID 123)
Time
08:45 - 09:55
AstraZeneca - Redefining long-term outcomes in newly diagnosed advanced ovarian cancer: Expert perspectives on integrating personalized medicine
(ID 125)
Time
08:45 - 10:15
Janssen - A Decade’s Perspective on Advances in Prostate Cancer
(ID 122)
Time
08:45 - 10:15
Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
(ID 127)
Time
10:30 - 12:00
AstraZeneca - Osimertinib in early- and late-stage NSCLC: Breaking new ground in EGFRm disease
(ID 129)
Time
10:30 - 12:00
Novartis - Improving Survival Outcomes in HR+/HER2− Advanced Breast Cancer: A Biological Perspective
(ID 126)
Time
10:30 - 12:00
BeiGene - A New Breath in Lung Cancer
(ID 128)
Time
10:30 - 12:00
Incyte - Making Precision Medicine a Reality for Patients with Cholangiocarcinoma
(ID 133)
Time
18:45 - 19:58
GSK - Biomarkers for cancer immunotherapy: the importance of dMMR/MSI-H for predicting response in solid tumors
(ID 130)
Time
18:45 - 20:15
Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
(ID 132)
Time
18:45 - 20:15
Astellas - The evolving landscape of advanced prostate cancer
(ID 131)
Time
18:45 - 20:15
Advanced Accelerator Applications, a Novartis Company - Cutting through the noise: How do GEP-NET patients stand to benefit from PRRT?
(ID 137)
Time
08:45 - 10:15